HMHilda MujuruMBChB, MMed Paeds, MSc Clin EpiVideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #13 Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (F/TAF) Plus Cobicistat-Boosted Protease Inhibitors in Children with HIV-1 Aged 2-<12 Years and Weighing 14-<40 kg: Week 48 Outcomes - Hilda Angela MujuruView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #14 Effectiveness and Safety of Dolutegravir (DTG) in Infants and Children Aged Under 12-Years at Start of DTG in Europe and Thailand - Intira Jeannie CollinsView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #15 Efficacy of Second-Line Dolutegravir- versus Boosted Protease Inhibitor-Based ART in Children and Adolescents Living with HIV at 96 and 144 Weeks: Pooled Analysis of the ODYSSEY and CHAPAS-4 Trials - Pauline AmugeView Video
VideoHIVTuberculosis17th International Workshop on Pediatrics & HIV 2025Abstract #17 Effect of TB Preventive Treatment on TB Incidence and Non-TB-Related Mortality among Children and Adolescents Living with HIV Initiated on Antiretroviral Therapy in Cameroon, 2020-2022 - Boris Kevin TchoungaView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #18 Infectious Morbidity among Children HIV-Exposed, Uninfected in South Africa: Elevated Risk in Infancy But Not Thereafter - Kim AndersonView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #19 Growth Trajectories Before and After Switching to Dolutegravir in Children Living with HIV in the ODYSSEY Trial - Man K. ChanView Video
NMNelly MugoMbCHB, MMed (ObGyn), MPHVideoHIV17th International Workshop on Pediatrics & HIV 2025 HPV Vaccine and Cervical Cancer Prevention in Africa - Nelly MugoView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #20 Telomere Length and Neurodevelopmental Outcomes among Children Exposed and Not Exposed to HIV in Kenya - Jillian NearyView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #21 Switching Off Dolutegravir in Pregnancy During the Safety Signal Period: A Multi-Cohort European Study - Georgina FernandesView Video
VideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #22 Causes of Death among Sub-Saharan African Infants Living with HIV and Hospitalised with Severe Pneumonia Using Minimally Invasive Autopsies in the EMPIRICAL Trial - Maria de la Cinta Moraleda RedecillaView Video
FKFatima KakkarMD, MPH, FRCPCVideoHIV17th International Workshop on Pediatrics & HIV 2025Abstract #23 Association Between Reservoir Size and Markers of Cardiovascular Inflammation in Perinatally Infected Children Living with HIV - Fatima KakkarView Video
VMVictor MusiimeMBChB, MMed, PhDVideoHIV17th International Workshop on Pediatrics & HIV 2025Debate: All Young Adults with Perinatal HIV Should Receive a Statin to Reduce the Risk of Cardiovascular-Related Morbidity and MortalityView Video
